New analyses on terbinafine susceptibility and MOB-015 published in Journal of Fungi

Data ReadoutpositiveMOB-015Positive

AI Analysis

Summary

Moberg Pharma announced publication of analyses showing potent antifungal activity of terbinafine (MOB-015) against dermatophytes causing onychomycosis, with mycological cure achieved across the studied population.

Outcome Details

New analyses demonstrating potent antifungal activity of terbinafine against dermatophytes causing onychomycosis; mycological cure achieved with MOB-015

Importance:4/10

Sentiment:

0.60

dermatologyfungal infectionantifungalpublicationefficacy data

Related Companies

$MOB

Read the original article

Published by PR Newswire Pharma on October 5, 2026 6:26 AM

Read Original